Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reinhard Dummer

Showing results (301-310 of 743) with videos related to

Pageof 75
Sort By:
Experimental Dermatology|April 17, 2025
Protein Kinase C Inhibition Overcomes Targeted Therapy Resistance in Cutaneous MelanomaCorinne I Stoffel, Ossia Eichhoff, Phil F Cheng, et al.
European Journal of Cancer (Oxford, England : 1990)|January 14, 2014
Metastatic basal cell carcinoma: prognosis dependent on anatomic site and spread of diseaseMargaret McCusker, Nicole Basset-Seguin, Reinhard Dummer, et al.
Plos One|March 24, 2012
Tumor cell plasticity and angiogenesis in human melanomasDaniela Mihic-Probst, Kristian Ikenberg, Marianne Tinguely, et al.
Journal of Cancer Research and Clinical Oncology|December 17, 2022
Combinational expression of tumor testis antigens NY-ESO-1, MAGE-A3, and MAGE-A4 predicts response to immunotherapy in mucosal melanoma patientsSandra N Freiberger, David Holzmann, Grégoire B Morand, et al.
Case Reports in Oncology|June 29, 2012
Detecting BRAF Mutations in Formalin-Fixed Melanoma: Experiences with Two State-of-the-Art TechniquesNicola L Schoenewolf, Reinhard Dummer, Daniela Mihic-Probst, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2008
Intralesional adenovirus-mediated interleukin-2 gene transfer for advanced solid cancers and melanomaReinhard Dummer, Christoph Rochlitz, Thierry Velu, et al.
Oncotarget|November 20, 2019
Characterizing CD44 regulatory microRNAs as putative therapeutic agents in human melanomaJohannes Fänder, Heike Kielstein, Maximilian Büttner, et al.
ESMO Open|August 5, 2020
Response assessment and outcome of combining immunotherapy and radiosurgery for brain metastasis from malignant melanomaEmilie Le Rhun, Fabian Wolpert, Maud Fialek, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 27, 2021
Establishing standardized immune phenotyping of metastatic melanoma by digital pathologyBettina Sobottka, Marta Nowak, Anja Laura Frei, et al.
The Journal of Investigative Dermatology|March 5, 2002
Bcl-2 and bcl-xL antisense oligonucleotides induce apoptosis in melanoma cells of different clinical stagesRobert A Olie, Christoph Hafner, Renzo Küttel, et al.
Pageof 75

Showing results (301-310 of 743) with videos related to

Sort By:
Pageof 75
Experimental Dermatology|April 17, 2025
Protein Kinase C Inhibition Overcomes Targeted Therapy Resistance in Cutaneous MelanomaCorinne I Stoffel, Ossia Eichhoff, Phil F Cheng, et al.
European Journal of Cancer (Oxford, England : 1990)|January 14, 2014
Metastatic basal cell carcinoma: prognosis dependent on anatomic site and spread of diseaseMargaret McCusker, Nicole Basset-Seguin, Reinhard Dummer, et al.
Plos One|March 24, 2012
Tumor cell plasticity and angiogenesis in human melanomasDaniela Mihic-Probst, Kristian Ikenberg, Marianne Tinguely, et al.
Journal of Cancer Research and Clinical Oncology|December 17, 2022
Combinational expression of tumor testis antigens NY-ESO-1, MAGE-A3, and MAGE-A4 predicts response to immunotherapy in mucosal melanoma patientsSandra N Freiberger, David Holzmann, Grégoire B Morand, et al.
Case Reports in Oncology|June 29, 2012
Detecting BRAF Mutations in Formalin-Fixed Melanoma: Experiences with Two State-of-the-Art TechniquesNicola L Schoenewolf, Reinhard Dummer, Daniela Mihic-Probst, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2008
Intralesional adenovirus-mediated interleukin-2 gene transfer for advanced solid cancers and melanomaReinhard Dummer, Christoph Rochlitz, Thierry Velu, et al.
Oncotarget|November 20, 2019
Characterizing CD44 regulatory microRNAs as putative therapeutic agents in human melanomaJohannes Fänder, Heike Kielstein, Maximilian Büttner, et al.
ESMO Open|August 5, 2020
Response assessment and outcome of combining immunotherapy and radiosurgery for brain metastasis from malignant melanomaEmilie Le Rhun, Fabian Wolpert, Maud Fialek, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 27, 2021
Establishing standardized immune phenotyping of metastatic melanoma by digital pathologyBettina Sobottka, Marta Nowak, Anja Laura Frei, et al.
The Journal of Investigative Dermatology|March 5, 2002
Bcl-2 and bcl-xL antisense oligonucleotides induce apoptosis in melanoma cells of different clinical stagesRobert A Olie, Christoph Hafner, Renzo Küttel, et al.
Pageof 75